St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive

被引：0
|
作者：
Liane Will-Shahab
Steffen Bauer
Ullrich Kunter
Ivar Roots
Axel Brattström
机构：
[1] BIOPHARM,Institute of Clinical Pharmacology, University Medical Centre Charité
[2] Humboldt University of Berlin,undefined
[3] Max Zeller & Söhne AG,undefined
来源：
European Journal of Clinical Pharmacology | 2009年 / 65卷
关键词：
Ze 117; Hypericum perforatum; St John’s wort; Hyperforin; Ethinylestradiol; 3-Ketodesogestrel; Interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PHARMACOKINETICS AND PROTEIN-BINDING OF GESTODENE UNDER TREATMENT WITH A LOW-DOSE COMBINATION ORAL-CONTRACEPTIVE FOR 3 MONTHS
    DIBBELT, L
    KNUPPEN, R
    KUHNZ, W
    JUTTING, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (09): : 1146 - 1152
  • [32] Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding
    Murphy, PA
    Kern, SE
    Stanczyk, FZ
    Westhoff, CL
    CONTRACEPTION, 2005, 71 (06) : 402 - 408
  • [33] URINARY HORMONAL PROFILE DURING THE 1ST CYCLE OF LOW-DOSE ORAL-CONTRACEPTIVE PILLS IN WOMEN
    OLLO, MA
    ELSOKKARY, H
    DARWISH, E
    KHAMIS, Y
    SOUKA, AR
    CONTRACEPTION, 1990, 42 (01) : 29 - 34
  • [34] SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF A LOW-DOSE ORAL-CONTRACEPTIVE IN WOMEN WITH CHRONIC-RENAL-FAILURE UNDERGOING PERITONEAL-DIALYSIS
    PRICE, TM
    DUPUIS, RE
    CARR, BR
    STANCZYK, FZ
    LOBO, RA
    DROEGEMUELLER, W
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (05) : 1400 - 1406
  • [35] High-dose St. John's wort extract as single dose - results of a post-marketing surveillance study including 11,246 patients
    Volz, HP
    Zeller, K
    NERVENHEILKUNDE, 2000, 19 (10) : 566 - 569
  • [36] Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort)
    Schempp, CM
    Winghofer, B
    Langheinrich, M
    Schöpf, E
    Simon, JC
    SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 1999, 12 (05): : 299 - 304
  • [37] St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier
    El Biali, Myriam
    Woelfl-Duchek, Michael
    Jackwerth, Matthias
    Mairinger, Severin
    Weber, Maria
    Bamminger, Karsten
    Poschner, Stefan
    Rausch, Ivo
    Schindler, Natalie
    Lozano, Irene Hernandez
    Jaeger, Walter
    Nics, Lukas
    Tournier, Nicolas
    Hacker, Marcus
    Zeitlinger, Markus
    Bauer, Martin
    Langer, Oliver
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [38] Plasma pharmacokinetics of low-dose oral busulfan in Fanconi's anaemia patients undergoing haematopoietic stem cell transplantation
    Kühl, J
    Jenke, A
    Schleier, E
    Freiberg-Richter, J
    Schuler, U
    Neitzel, H
    Ebell, W
    BONE MARROW TRANSPLANTATION, 2004, 33 : S110 - S111
  • [39] Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive
    Westhoff, Carolyn L.
    Hait, Howard I.
    Reape, Kathleen Z.
    CONTRACEPTION, 2012, 85 (03) : 235 - 239
  • [40] Single-dose and steady-state administration of Hypericum perforatum extract (St John's Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation
    Schempp, CM
    Müller, K
    Winghofer, B
    Schulte-Mönting, J
    Simon, JC
    ARCHIVES OF DERMATOLOGY, 2001, 137 (04) : 512 - 513
12345